Want to join the conversation?
For 4Q16, $INTC expects revenue to be in the range of $15.2-16.2Bil, and gross margin of 61%, plus or minus a couple percentage points. Research and development plus marketing, general and administrative expenses are expected to be about $5.2Bil and depreciation is projected to be about $1.5Bil for 4Q16.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?